Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Catalent Pharma Solutions welcomed Lexicon Pharmaceuticals’ announcement that Xermelo, has been approved by the U.S. Food and Drug Administration (FDA).
read more
INC Research Holdings and inVentiv Health announced their Boards of Directors have approved a definitive merger agreement pursuant to which their businesses would combine in an all-stock transaction.
read more
The Addario Lung Cancer Medical Institute (ALCMI) and Biocept announce a clinical collaboration and initiation of ALCMI-009 liquid biopsy clinical trial.
read more
ERT announced the acquisition of ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center.
read more
Check-Cap and GE Healthcare announced the companies have achieved the initial milestone in their collaboration to develop high-volume, X-ray capsule manufacturing capabilities.
read more
BioPharmaSpec announced it is expanding its in-house capabilities for characterizing higher order protein structure.
read more
Carmell Therapeutics recently held a pre-IND meeting with the FDA, advancing the company's clinical and regulatory strategies and driving the company's need to expand its manufacturing facilities.
read more
AMRI reported financial and operating results for the first quarter ended March 31, 2017 and provided an update to its outlook for 2017.
read more
ERT announced the acquisition of ImageIQ, originally established as Cleveland Clinic’s Biomedical Imaging and Analysis Center.
read more
Exscientia announced a strategic research collaboration, and license option agreement with Sanofi in metabolic disease.
read more
Regeneron Pharmaceuticals announced a clinical and supply agreement for a Phase 1b dose-escalation study in renal cell carcinoma.
read more
Dalton Pharma Services announced the signing of a drug development and manufacturing services agreement with Arch Biopartners.
read more
Patheon announced it has completed an expansion project at its Greenville, NC manufacturing site.
read more
PDD announced the creation of a dedicated unit combining its medical affairs research operations team and Evidera to demonstrate the real-world effectiveness, safety and value of biopharmaceutical and biotechnology products.
read more
Croda announced all its excipient manufacturing sites globally are now EXCiPACT certified.
read more